Advanced search
Publication Cover
Expert Opinion on Drug Discovery Volume 4, 2009 - Issue 1
Submit an article Journal homepage
78
Views
4
CrossRef citations to date
0
Altmetric
Editorial

What is the future for drug development in atherosclerosis and dyslipidaemia?

Keith Suckling 291 Knightsfield, Welwyn Garden City, Herts AL8 7NH, UK +44 1707 330022; +44 1707 330022; [email protected]
Pages 1-3 | Published online: 15 Dec 2008
 
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Abstract

Major companies have recently announced a reduction or termination of their work in cardiovascular disease, specifically atherosclerosis and dyslipidaemia. This editorial considers the background to these developments, relating it to the continuing development of the lipoprotein-associated phospholipase A2 inhibitor darapladib and the potential for the field in the future.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,340.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.